Guo Xiang Cheng
Directeur Général chez Shanghai Genon Biological Product Co., Ltd.
Profil
Guo Xiang Cheng is currently the Chairman & General Manager at Shanghai Genon Biological Product Co., Ltd., Chairman at Shanghai Rui Dong Hospital, Chairman at Shanghai Transgenic Research Center, and President-Biotechnology at Tongji University.
He holds a doctorate degree from Shanghai Jiao Tong University, conferred in 1998, and an undergraduate degree from Yangzhou University, conferred in 1985.
Postes actifs de Guo Xiang Cheng
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Genon Biological Product Co., Ltd.
 Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Directeur Général | - |
| Shanghai Rui Dong Hospital | Président | 10/03/2010 |
| Shanghai Transgenic Research Center | Président | 10/03/2010 |
| Tongji University | Corporate Officer/Principal | 10/03/2010 |
Formation de Guo Xiang Cheng
| Shanghai Jiao Tong University | Doctorate Degree |
| Yangzhou University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Shanghai Genon Biological Product Co., Ltd.
Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Rui Dong Hospital | |
| Shanghai Transgenic Research Center |
